Search research articles
Contact Us
Filters
Showing results (91-100 of 333) with videos related to
Page
of 34
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 12, 2001
Chemotherapy in elderly patients with colorectal cancer
C H Köhne, A Grothey, C Bokemeyer, et al.
Anticancer Research
|
June 25, 2003
Phase II trial of trofosfamide in patients with advanced pretreated soft tissue sarcomas
J T Hartmann, K Oechsle, F Mayer, et al.
Anti-Cancer Drugs
|
July 1, 1997
Weekly short infusions of gemcitabine are not associated with suppression of lymphatic activity in patients with solid tumors
T Daikeler, K Maas, J T Hartmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 13, 1998
Chemotherapy for germ cell tumors relapsing after high-dose chemotherapy and stem cell support: a retrospective multicenter study of the Austrian Study Group on Urologic Oncology
J Pont, C Bokemeyer, A Harstrick, et al.
General Hospital Psychiatry
|
October 7, 2015
Anxiety and depression in long-term testicular germ cell tumor survivors
S Vehling, A Mehnert, M Hartmann, et al.
Oncology Reports
|
May 21, 2011
Late relapse of testicular cancer presenting as differentiated teratoma - report of a case and discussion of the clinical implications
C Bokemeyer, M Kuczyk, B Fichna, et al.
International Journal of Oncology
|
May 14, 2011
5-ht3 antagonist ondansetron for the treatment of chemotherapy-induced nausea and vomiting in an outpatient population
J Casper, S Casper, C Kohnewompner, et al.
Oncology Reports
|
May 25, 2011
Immunohistochemical detection of cathepsin-d expression in prostate-cancer
M Kuczyk, J Serth, C Bokemeyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 4, 2000
Identification of prognostic subgroups among patients with metastatic 'IGCCCG poor-prognosis' germ-cell cancer: an explorative analysis using cart modeling
C Kollmannsberger, C Nichols, C Meisner, et al.
Anti-Cancer Drugs
|
September 1, 1996
Amifostine does not alter the antitumor activity of cisplatin in a pre-clinical model of testicular cancer
T A Dunn, H J Schmoll, V Grünwald, et al.
Page
of 34
Search research articles
Search
Showing results (91-100 of 333) with videos related to
Sort By:
Page
of 34
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 12, 2001
Chemotherapy in elderly patients with colorectal cancer
C H Köhne, A Grothey, C Bokemeyer, et al.
Anticancer Research
|
June 25, 2003
Phase II trial of trofosfamide in patients with advanced pretreated soft tissue sarcomas
J T Hartmann, K Oechsle, F Mayer, et al.
Anti-Cancer Drugs
|
July 1, 1997
Weekly short infusions of gemcitabine are not associated with suppression of lymphatic activity in patients with solid tumors
T Daikeler, K Maas, J T Hartmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 13, 1998
Chemotherapy for germ cell tumors relapsing after high-dose chemotherapy and stem cell support: a retrospective multicenter study of the Austrian Study Group on Urologic Oncology
J Pont, C Bokemeyer, A Harstrick, et al.
General Hospital Psychiatry
|
October 7, 2015
Anxiety and depression in long-term testicular germ cell tumor survivors
S Vehling, A Mehnert, M Hartmann, et al.
Oncology Reports
|
May 21, 2011
Late relapse of testicular cancer presenting as differentiated teratoma - report of a case and discussion of the clinical implications
C Bokemeyer, M Kuczyk, B Fichna, et al.
International Journal of Oncology
|
May 14, 2011
5-ht3 antagonist ondansetron for the treatment of chemotherapy-induced nausea and vomiting in an outpatient population
J Casper, S Casper, C Kohnewompner, et al.
Oncology Reports
|
May 25, 2011
Immunohistochemical detection of cathepsin-d expression in prostate-cancer
M Kuczyk, J Serth, C Bokemeyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 4, 2000
Identification of prognostic subgroups among patients with metastatic 'IGCCCG poor-prognosis' germ-cell cancer: an explorative analysis using cart modeling
C Kollmannsberger, C Nichols, C Meisner, et al.
Anti-Cancer Drugs
|
September 1, 1996
Amifostine does not alter the antitumor activity of cisplatin in a pre-clinical model of testicular cancer
T A Dunn, H J Schmoll, V Grünwald, et al.
Page
of 34